{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:20Z","timestamp":1791314360780,"version":"4.3.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.nbd.2008.02.010","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T17:01:56Z","timestamp":1205168516000},"page":"375-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Beneficial effects of rolipram in the R6\/2 mouse model of Huntington's disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Zena","family":"DeMarch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Giamp\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Patassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.02.010_bb0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.02.010_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-2236(95)93943-R","article-title":"Genetics and molecular biology of Huntington's disease","volume":"18","author":"Albin","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.02.010_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0169-328X(97)00180-0","article-title":"Localization of putative calcium-responsive regions in the rat BDNF gene","volume":"50","author":"Bishop","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"17","key":"10.1016\/j.nbd.2008.02.010_bb0025","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1097\/00001756-199712010-00033","article-title":"Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats","volume":"8","author":"Block","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.02.010_bb0030","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/00001756-200105250-00041","article-title":"Rolipram reduces excitotoxic neuronal damage","volume":"12","author":"Block","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.02.010_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2003.10.058","article-title":"Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion","volume":"998","author":"Block","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.02.010_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2007.03.033","article-title":"Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation","volume":"418","author":"Chen","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.02.010_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","article-title":"Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect","volume":"407","author":"Cherry","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1471-4159.1994.63020509.x","article-title":"Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents","volume":"63","author":"Condorelli","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.02.010_bb0055","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","article-title":"Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport","volume":"17","author":"Conner","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0060","first-page":"431","article-title":"Analysis of neurotransmitter metabolites and adenosine 3\u2032,5\u2032-monophosphate in the CSF of patients with extrapyramidal motor disorders","volume":"40","author":"Cramer","year":"1984","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.02.010_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.nbd.2006.09.006","article-title":"Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity","volume":"25","author":"DeMarch","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.02.010_bb0075","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.02.010_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0893-133X(99)00084-6","article-title":"Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus","volume":"22","author":"Fujimaki","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2008.02.010_bb0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","article-title":"Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease","volume":"23","author":"Giampa","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0105","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2008.02.010_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(02)04275-0","article-title":"Overexpression of heat shock protein 70 in R6\/2 Huntington's disease mice has only modest effects on disease progression","volume":"970","author":"Hansson","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.02.010_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0143-4160(98)90111-7","article-title":"Mechanisms controlling gene expression by nuclear calcium signals","volume":"23","author":"Hardingham","year":"1998","journal-title":"Cell Calcium"},{"key":"10.1016\/j.nbd.2008.02.010_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2008.02.010_bb0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","article-title":"Translating therapies for Huntington's disease from genetic animal models to clinical trials","volume":"1","author":"Hersch","year":"2004","journal-title":"NeuroRx"},{"issue":"2","key":"10.1016\/j.nbd.2008.02.010_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","article-title":"Environmental enrichment slows disease progression in R6\/2 Huntington's disease mice","volume":"51","author":"Hockly","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00702-002-0797-1","article-title":"Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain","volume":"110","author":"Hosoi","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.nbd.2008.02.010_bb0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.084","article-title":"Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats","volume":"498","author":"Itoh","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0705927","article-title":"Role of PDE4 in superoxide anion generation through p44\/42MAPK regulation: a cAMP and a PKA-independent mechanism","volume":"143","author":"Jacob","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddg002","article-title":"Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein","volume":"12","author":"Jiang","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0270(99)00142-9","article-title":"A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections","volume":"93","author":"Jiao","year":"1999","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2008.02.010_bb0160","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.02.010_bb0165","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1097\/00001756-199912160-00031","article-title":"Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice","volume":"10","author":"Kosinski","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2008.02.010_bb0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.20259","article-title":"cAMP response element-binding protein activation in ligation preconditioning in neonatal brain","volume":"56","author":"Lee","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0175","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","article-title":"Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.02.010_bb0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.02.010_bb0185","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington's disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.02.010_bb0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj3470571","article-title":"Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells","volume":"347","author":"MacKenzie","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2008.02.010_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.02.010_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.npp.1300813","article-title":"Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear","volume":"31","author":"Monti","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2008.02.010_bb0220","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.bjp.0704629","article-title":"Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats","volume":"135","author":"Nagakura","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0225","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0230","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.02.010_bb0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using mynocicline and coenzyme Q in R6\/2 muse model of Huntington's disease","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim. Biophys."},{"key":"10.1016\/j.nbd.2008.02.010_bb0240","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.02.010_bb0245","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.02.010_bb0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0255","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2008.02.010_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-328X(96)00144-1","article-title":"The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic\u2013ischemic brain damage and repair","volume":"43","author":"Walton","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2008.02.010_bb0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0166-2236(99)01500-3","article-title":"Is CREB a key to neuronal survival?","volume":"23","author":"Walton","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01688638708405354","article-title":"Memory failure in Huntington's disease","volume":"9","author":"Wilson","year":"1987","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.nbd.2008.02.010_bb0275","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2008.02.010_bb0280","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/j.1460-2075.1990.tb07564.x","article-title":"Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors","volume":"9","author":"Zafra","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2008.02.010_bb0285","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1523\/JNEUROSCI.12-12-04793.1992","article-title":"Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes","volume":"12","author":"Zafra","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.02.010_bb0290","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.02.010_bb0295","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:02:22Z","timestamp":1760850142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0969996108000405"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.02.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}